A New Look at Atara Biotherapeutics Inc (ATRA) Stock’s Hidden Strategies

Mizuho lowered the price target for the Atara Biotherapeutics Inc (NASDAQ:ATRA) stock from “a Buy” to “a Neutral”. The rating was released on November 09, 2023, according to finviz. The stock was downgraded by Citigroup, who disclosed in a research note on July 20, 2022, from Neutral to Sell and set the price objective to […]

A New Look at Atara Biotherapeutics Inc (ATRA) Stock’s Hidden Strategies

Mizuho lowered the price target for the Atara Biotherapeutics Inc (NASDAQ:ATRA) stock from “a Buy” to “a Neutral”. The rating was released on November 09, 2023, according to finviz. The stock was downgraded by Citigroup, who disclosed in a research note on July 20, 2022, from Neutral to Sell and set the price objective to […]

A Tale from the Dusty Corner: Atara Biotherapeutics Inc (ATRA) Stock

Mizuho lowered the price target for the Atara Biotherapeutics Inc (NASDAQ:ATRA) stock from “a Buy” to “a Neutral”. The rating was released on November 09, 2023, according to finviz. The stock was downgraded by Citigroup, who disclosed in a research note on July 20, 2022, from Neutral to Sell and set the price objective to […]

Are Atara Biotherapeutics Inc’s (ATRA) stock prices rising too high?

Mizuho lowered the price target for the Atara Biotherapeutics Inc (NASDAQ:ATRA) stock from “a Buy” to “a Neutral”. The rating was released on November 09, 2023, according to finviz. The stock was downgraded by Citigroup, who disclosed in a research note on July 20, 2022, from Neutral to Sell and set the price objective to […]

What does the future hold for Atara Biotherapeutics Inc (ATRA) Stock?

Mizuho lowered the price target for the Atara Biotherapeutics Inc (NASDAQ:ATRA) stock from “a Buy” to “a Neutral”. The rating was released on November 09, 2023, according to finviz. The stock was downgraded by Citigroup, who disclosed in a research note on July 20, 2022, from Neutral to Sell and set the price objective to […]

Yummy or too sour? Atara Biotherapeutics Inc (ATRA) Stock

Mizuho lowered the price target for the Atara Biotherapeutics Inc (NASDAQ:ATRA) stock from “a Buy” to “a Neutral”. The rating was released on November 09, 2023, according to finviz. The stock was downgraded by Citigroup, who disclosed in a research note on July 20, 2022, from Neutral to Sell and set the price objective to […]

Where are Investors’ Sentiments? Atara Biotherapeutics Inc (ATRA) Stock

Mizuho lowered the price target for the Atara Biotherapeutics Inc (NASDAQ:ATRA) stock from “a Buy” to “a Neutral”. The rating was released on November 09, 2023, according to finviz. The stock was downgraded by Citigroup, who disclosed in a research note on July 20, 2022, from Neutral to Sell and set the price objective to […]